University Of Pittsburgh

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1787-02-28

Employees: 10K

Market Cap: -

Website: http://www.pitt.edu

Clinical Trials

Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia

Not Applicable

Completed

Conditions: HIV Infection

Interventions: Drug: Raltegravir (MK-0518)

First Posted Date: 2008-02-20

Last Posted Date: 2017-02-01

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 10

Registration Number: NCT00618371

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Cardiology Prevention in Systemic Lupus Erythematosus (SLE)

Not Applicable

Withdrawn

Conditions: Systemic Lupus Erythematosus

Interventions: Other: Preventive Cardiology
Other: Usual Care

First Posted Date: 2008-02-08

Last Posted Date: 2016-01-15

Lead Sponsor: University of Pittsburgh

Registration Number: NCT00610805

Locations: 🇺🇸
Lupus Center of Excellence, Magee Womens Hospital, 300 Halket St, Suite 1750, Pittsburgh, Pennsylvania, United States
🇺🇸
Clinical and Translational Research Center (CTRC), Montefiore Hospital, 6NE, 200 Lothrop St., Pittsburgh, Pennsylvania, United States

Exercise Training Study for Patients With Cystic Fibrosis

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Behavioral: Self-Regulated Exercise with Telephone Reinforcement
Behavioral: Standard Treatment
Behavioral: Qualitative Approach

First Posted Date: 2008-02-06

Last Posted Date: 2016-02-19

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 38

Registration Number: NCT00609050

Locations: 🇺🇸
Antiono J & Janet Palumbo Cystic Fibrosis Center; Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States

PET Imaging Study of Recovered Anorexics

Not Applicable

Completed

Conditions: Anorexia Nervosa

Interventions: Drug: Fluoxetine

First Posted Date: 2008-01-28

Last Posted Date: 2016-09-23

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 23

Registration Number: NCT00603018

Locations: 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders

Phase 1

Completed

Conditions: Attention Deficit and Disruptive Behavior Disorders

Interventions: Behavioral: Doctor-office collaborative care (DOCC) management
Behavioral: Treatment as usual (TAU)

First Posted Date: 2008-01-25

Last Posted Date: 2015-06-01

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 858

Registration Number: NCT00600470

Locations: 🇺🇸
Western Psychiatric Institute and Clinic (WPIC), Pittsburgh, Pennsylvania, United States

Patient Preference Survey for Radiation Oncologists

Not Applicable

Completed

Conditions: Prostate Cancer
Lung Cancer
Breast Cancer

Interventions: Behavioral: Physician behavior related to Patient Preference Survey
Other: Patient Preference Results

First Posted Date: 2008-01-16

Last Posted Date: 2017-07-25

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 500

Registration Number: NCT00595218

Locations: 🇺🇸
UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States

Feasibility of Mindfulness Meditation for Adults 65+ With Chronic Low Back Pain

Phase 2

Completed

Conditions: Chronic Low Back Pain

Interventions: Behavioral: Mindfulness based stress reduction program
Other: Wait-list control

First Posted Date: 2008-01-15

Last Posted Date: 2008-01-15

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 37

Registration Number: NCT00594243

Antimanic Drug Use in Pregnancy

Completed

Conditions: Bipolar Disorder
Pregnancy

First Posted Date: 2008-01-03

Last Posted Date: 2013-10-07

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 201

Registration Number: NCT00585702

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA

Completed

Conditions: Cystic Fibrosis
Allergic Bronchopulmonary Aspergillosis

First Posted Date: 2008-01-03

Last Posted Date: 2016-02-15

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 79

Registration Number: NCT00585364

Locations: 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States

Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck

Phase 2

Completed

Conditions: Adenoid Cystic Carcinoma

Interventions: Drug: doxorubicin and bortezomib

First Posted Date: 2007-12-27

Last Posted Date: 2016-11-06

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 10

Registration Number: NCT00581360

Locations: 🇺🇸
UPMC Cancer Center - Teramana Cancer Center - Steubenville, Steubenville, Ohio, United States
🇺🇸
UPMC Cancer Center - Beaver, Beaver, Pennsylvania, United States
🇺🇸
UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg, Greensburg, Pennsylvania, United States

and more 18 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy